First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
When mobile phones were first made available to consumers more than thirty years ago, it was difficult to imagine that they would become the hubs o
In This Quarter’s Report, We Identify High-usage Brand Name Drugs and Their Generic Alternatives. Each quarter, Mitchell Pharmacy So
October 2018 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Executive Vice-President, ADESA Analytical
The change in the complexity of vehicles over the last five years is absolutely staggering.
Getting injured on the job or in an auto accident can have a significant impact on a person’s life.
Each quarter, I round up and highlight some of my favorite articles written by Mitchell experts and let you know where we have been published outsi